Roca Therapeutics completes seed funding round
Roca Therapeutics completes seed funding round Series A funding round initiated to further fund the…
Roca Therapeutics completes seed funding round Series A funding round initiated to further fund the…
Internet City, Dubai–(Newsfile Corp. – September 22, 2022) – LBank Exchange, a global digital asset…
London, United Kingdom–(Newsfile Corp. – September 22, 2022) – In the stream of the G20…
ZURICH, SWITZERLAND, Sep 22, 2022 – (JCN Newswire) – Hitachi Energy today announced the launch…
HONG KONG, Sep 22, 2022 – (ACN Newswire) – Agilis Robotics Limited (“Agilis Robotics” or…
SEOUL, KOREA, Sept 22, 2022 – (ACN Newswire) – Starflex-VR Inc. has launched a K-pop…
Provides greater security and flexibility to Orange customers Unleashes unparalleled service coverage, performance, and resilience…
SCHAUMBURG, Ill.–(BUSINESS WIRE)–#isaca–Bringing together global industry experts and thought leaders, ISACA Conference Europe, 19-21 October…
CUTRA Co., Ltd., a fast-growing manufacturing company specializing in high technology launches CtrlAX, an innovative…
HONG KONG, Sep 22, 2022 – (ACN Newswire) – The restricted shares of Arrail Group…
Singapore, Sep 22, 2022 – (ACN Newswire) – Unicommerce, an integrated SaaS platform for post-purchase…
Customers in Australia, India, and Japan can now service traffic locally while benefiting from Cloudflare’s…
SAN JOSE, Calif.–(BUSINESS WIRE)–United Kingdom-based Canterbury Christ Church University, a long-standing customer of YuJa, Inc.,…
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
Montrouge, France, September 21, 2022 DBV Technologies Provides Clinical Update on VITESSE Phase 3 Trial…
Publication includes the Phase 3 VALOR SOD1-ALS trial and its open-label-extension study, underscoring the importance…
TORONTO and HOUSTON, Sept. 21, 2022 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or the…
Sino Biopharm a leading Chinese pharmaceutical group, through CTTQ will oversee the development and commercialization…
• Company on track to submit European marketing application in Q4 2022 • No additional…
SAN FRANCISCO and SAN DIEGO, Sept. 21, 2022 (GLOBE NEWSWIRE) — Kinnate Biopharma Inc. (Nasdaq:…